Envestnet Asset Management Inc. Sells 8,952 Shares of U.S. Physical Therapy, Inc. $USPH

Envestnet Asset Management Inc. trimmed its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 337,208 shares of the company’s stock after selling 8,952 shares during the period. Envestnet Asset Management Inc. owned about 2.22% of U.S. Physical Therapy worth $28,646,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Allspring Global Investments Holdings LLC bought a new stake in U.S. Physical Therapy in the third quarter worth $845,000. Geode Capital Management LLC grew its position in shares of U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after buying an additional 4,306 shares during the last quarter. Bank of New York Mellon Corp increased its position in U.S. Physical Therapy by 4.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock valued at $10,288,000 after purchasing an additional 6,190 shares during the period. CenterBook Partners LP increased its position in shares of U.S. Physical Therapy by 189.0% during the second quarter. CenterBook Partners LP now owns 47,014 shares of the company’s stock valued at $3,676,000 after buying an additional 30,746 shares during the period. Finally, Koshinski Asset Management Inc. purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $226,000.

U.S. Physical Therapy Stock Down 1.0%

U.S. Physical Therapy stock opened at $87.25 on Friday. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $93.50. The stock has a fifty day simple moving average of $82.27 and a two-hundred day simple moving average of $81.93. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 36.66, a PEG ratio of 3.64 and a beta of 1.30.

Analyst Ratings Changes

A number of research analysts recently issued reports on USPH shares. Barrington Research reissued an “outperform” rating and set a $103.00 price target on shares of U.S. Physical Therapy in a research report on Monday, January 5th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. JPMorgan Chase & Co. cut their price target on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Monday, November 24th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. Four analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus target price of $105.33.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.